Pretransfusion Testing Thesis Topics

This page covers clinically feasible immunohematology and pretransfusion testing thesis ideas for MD Transfusion Medicine candidates, including ABO and Rh grouping discrepancies, red cell antibody screening and identification, compatibility testing, crossmatching, alloimmunisation, autoimmunisation, direct antiglobulin testing, extended red cell phenotyping and selected molecular genotyping. These projects can usually be completed within one thesis period using routine pretransfusion samples, serological platforms and blood-bank records already available in a tertiary care transfusion service. The emphasis is on immunohematology thesis topics, pretransfusion testing research topics, MD Transfusion Medicine protocol and MD Transfusion Medicine synopsis choices that can be converted into a focused protocol or synopsis without making the project dependent on non-routine resources.

Last reviewed and updated: September 2026 · 2026–27 admissions

Our MD Transfusion Medicine Thesis Guidance provides structured protocols, blood bank safety standards, and institutional review board (IRB) layout guides.

ABO and Rh Blood Grouping and Blood Group Discrepancies

Assessment of the prevalence and causes of ABO blood group discrepancies among patients undergoing pre-transfusion testing at a tertiary care hospital: a cross-sectional observational study.
Comparison of forward and reverse ABO grouping discrepancies among adult and paediatric patients: a comparative cross-sectional study.
Assessment of ABO blood group distribution among blood donors and transfusion recipients in a tertiary care centre: a cross-sectional observational study.
Comparison of ABO blood group frequencies between voluntary blood donors and hospitalised patients: a comparative cross-sectional study.
Assessment of RhD blood group distribution among blood donors attending a tertiary care blood centre: a cross-sectional study.
Comparison of RhD-negative blood group frequency between male and female blood donors: a comparative cross-sectional study.
Assessment of weak reactions in routine ABO blood grouping and their underlying causes: a cross-sectional observational study.
Comparison of manual tube and column agglutination methods for ABO and RhD blood grouping: a comparative cross-sectional study.
Assessment of concordance between slide, tube and column agglutination techniques for ABO blood grouping: a comparative cross-sectional study.
Comparison of RhD typing results obtained by conventional tube and column agglutination methods: a comparative cross-sectional study.
Assessment of the frequency of weak D phenotypes among apparently RhD-negative blood donors: a cross-sectional observational study.
Comparison of weak D detection by indirect antiglobulin testing and column agglutination technology: a comparative cross-sectional study.
Assessment of causes of mixed-field agglutination encountered during ABO blood grouping: a cross-sectional observational study.
Comparison of ABO grouping discrepancies in recently transfused and non-transfused patients: a comparative cross-sectional study.
Assessment of ABO blood group discrepancies associated with haematological malignancies: a cross-sectional observational study.
Comparison of blood group discrepancies among medical, surgical and obstetric patients: a comparative cross-sectional study.
Assessment of ABO discrepancies due to weak or missing antibodies in reverse grouping among elderly patients: a cross-sectional observational study.
Comparison of reverse grouping reaction strength among different adult age groups: a comparative cross-sectional study.
Assessment of ABO discrepancies caused by weak antigen expression in patients with haematological disorders: a cross-sectional observational study.
Comparison of ABO subgroup frequency among blood donors and patients referred for immunohematology work-up: a comparative cross-sectional study.
Assessment of A2 and A2B subgroups among group A and group AB individuals: a cross-sectional observational study.
Comparison of anti-A1 antibody prevalence among A2 and A2B individuals: a comparative cross-sectional study.
Assessment of serological characteristics of suspected ABO subgroups encountered during routine grouping: a cross-sectional observational study.
Comparison of monoclonal antisera from different manufacturers for ABO and RhD blood grouping: a comparative cross-sectional study.
Assessment of clerical and technical errors contributing to discrepant blood grouping results in a transfusion service: a cross-sectional observational study.
Comparison of blood grouping errors identified during initial testing and repeat verification: a comparative cross-sectional study.
Assessment of blood group discrepancy patterns among neonates and infants undergoing pre-transfusion testing: a cross-sectional observational study.
Comparison of ABO grouping performance using cord blood and peripheral venous blood samples in neonates: a comparative cross-sectional study.
Assessment of rouleaux-related ABO grouping discrepancies among patients with hyperproteinaemia: a cross-sectional observational study.
Comparison of saline replacement and washed-cell techniques for resolution of rouleaux-associated blood grouping discrepancies: a comparative cross-sectional study.
Assessment of RhD typing discrepancies in patients with weak or variant antigen expression: a cross-sectional observational study.
Comparison of RhD typing results using immediate-spin and antiglobulin-phase methods: a comparative cross-sectional study.
Assessment of frequency and causes of ABO typing discrepancies in emergency transfusion samples: a cross-sectional observational study.
Comparison of ABO discrepancy rates in samples received from emergency and elective clinical areas: a comparative cross-sectional study.
Assessment of blood grouping discrepancies associated with sample quality and pre-analytical errors: a cross-sectional observational study.
Comparison of ABO and RhD grouping results in venous samples collected in ethylenediaminetetraacetic acid and plain tubes: a comparative cross-sectional study.
Assessment of blood group distribution and rare ABO phenotypes among donors in a tertiary care blood centre: a cross-sectional observational study.
Comparison of ABO and RhD blood group distribution across different age groups of blood donors: a comparative cross-sectional study.
Assessment of concordance between historical and current ABO and RhD blood group records in repeatedly tested patients: a cross-sectional observational study.
Comparison of routine serological grouping and automated blood grouping systems for detection of ABO and RhD discrepancies: a comparative cross-sectional study.

Red Cell Antibody Screening and Identification

Prevalence of unexpected red cell antibodies among patients undergoing pre-transfusion antibody screening at a tertiary care hospital: a cross-sectional observational study.
Comparison of red cell antibody screen positivity between previously transfused and non-transfused patients: a comparative cross-sectional study.
Assessment of unexpected red cell antibody prevalence among multitransfused patients: a cross-sectional observational study.
Comparison of antibody screening positivity among medical, surgical and obstetric patients: a comparative cross-sectional study.
Assessment of clinically significant red cell antibodies among patients with positive antibody screens: a cross-sectional observational study.
Comparison of alloantibody specificity among male and female patients with positive antibody screening results: a comparative cross-sectional study.
Assessment of the frequency of anti-E, anti-c, anti-K and other clinically significant red cell antibodies in a tertiary care hospital: a cross-sectional observational study.
Comparison of antibody detection by conventional tube and column agglutination methods: a comparative cross-sectional study.
Assessment of concordance between solid-phase and column agglutination methods for red cell antibody screening: a comparative cross-sectional study.
Comparison of two-cell and three-cell screening panels for detection of unexpected red cell antibodies: a comparative cross-sectional study.
Assessment of antibody screening positivity among patients with thalassaemia receiving regular transfusions: a cross-sectional observational study.
Comparison of red cell antibody profiles in thalassaemia and sickle cell disease patients: a comparative cross-sectional study.
Assessment of red cell antibodies among patients with chronic kidney disease undergoing repeated transfusions: a cross-sectional observational study.
Comparison of antibody screening results in oncology and non-oncology multitransfused patients: a comparative cross-sectional study.
Assessment of unexpected red cell antibodies among antenatal women: a cross-sectional observational study.
Comparison of antibody screening positivity between RhD-negative and RhD-positive pregnant women: a comparative cross-sectional study.
Assessment of clinically significant maternal red cell antibodies detected during antenatal screening: a cross-sectional observational study.
Comparison of antibody identification patterns among pregnant women and transfusion-dependent patients: a comparative cross-sectional study.
Assessment of multiple alloantibodies among patients referred for antibody identification: a cross-sectional observational study.
Comparison of single and multiple red cell alloantibodies with respect to patient transfusion history: a comparative cross-sectional study.
Assessment of panreactivity patterns encountered during antibody identification and their underlying immunohematological causes: a cross-sectional observational study.
Comparison of antibody reactivity at immediate-spin, 37 degrees Celsius and antiglobulin phases: a comparative cross-sectional study.
Assessment of cold-reactive antibodies among samples showing unexpected agglutination during antibody screening: a cross-sectional observational study.
Comparison of clinically significant and clinically insignificant red cell antibodies according to reaction temperature and phase: a comparative cross-sectional study.
Assessment of the role of autocontrol in differentiating alloantibodies from autoantibodies during antibody investigation: a cross-sectional observational study.
Comparison of antibody screening results using pooled screening cells and commercial screening cell panels: a comparative cross-sectional study.
Assessment of the frequency of dosage-dependent red cell antibodies detected during antibody identification: a cross-sectional observational study.
Comparison of enzyme-treated and untreated reagent red cells for antibody identification in selected positive samples: a comparative cross-sectional study.
Assessment of antibody identification challenges caused by recently transfused mixed red cell populations: a cross-sectional observational study.
Comparison of antibody specificity according to ABO and RhD blood group of recipients: a comparative cross-sectional study.
Assessment of the association between number of previous transfusions and antibody screen positivity: a cross-sectional observational study.
Comparison of antibody screen positivity among patients receiving fewer and greater numbers of previous transfusions: a comparative cross-sectional study.
Assessment of positive antibody screening results in patients without documented transfusion history: a cross-sectional observational study.
Comparison of antibody prevalence in first-time transfusion recipients and previously transfused recipients: a comparative cross-sectional study.
Assessment of red cell antibody screening positivity among elderly patients undergoing pre-transfusion testing: a cross-sectional observational study.
Comparison of unexpected antibody prevalence across different age groups of transfusion recipients: a comparative cross-sectional study.
Assessment of antibody screening and identification turnaround time in a tertiary care transfusion service: a cross-sectional observational study.
Comparison of antibody identification success using standard panel interpretation and selected-cell testing: a comparative cross-sectional study.
Assessment of inconclusive antibody identification patterns and the common factors associated with them: a cross-sectional observational study.
Comparison of antibody screening positivity detected by manual and automated immunohematology platforms: a comparative cross-sectional study.

Compatibility Testing and Crossmatching

Assessment of incompatible crossmatches and their causes among patients undergoing pre-transfusion testing: a cross-sectional observational study.
Comparison of incompatible crossmatch rates among medical, surgical and obstetric patients: a comparative cross-sectional study.
Assessment of the causes of major crossmatch incompatibility in a tertiary care hospital: a cross-sectional observational study.
Comparison of immediate-spin and antiglobulin crossmatching in patients with negative antibody screening results: a comparative cross-sectional study.
Assessment of concordance between electronic crossmatching and serological crossmatching in eligible patients: a comparative cross-sectional study.
Comparison of conventional tube and column agglutination methods for compatibility testing: a comparative cross-sectional study.
Assessment of crossmatch incompatibility among multitransfused patients: a cross-sectional observational study.
Comparison of compatibility testing outcomes between first-time and previously transfused recipients: a comparative cross-sectional study.
Assessment of incompatible crossmatches due to unexpected alloantibodies: a cross-sectional observational study.
Comparison of crossmatch incompatibility in antibody screen-positive and antibody screen-negative patients: a comparative cross-sectional study.
Assessment of incompatible crossmatches associated with positive direct antiglobulin tests: a cross-sectional observational study.
Comparison of crossmatch results in patients with positive and negative autocontrols: a comparative cross-sectional study.
Assessment of crossmatch-to-transfusion ratio in elective surgical patients: a cross-sectional observational study.
Comparison of crossmatch-to-transfusion ratio among different surgical specialties: a comparative cross-sectional study.
Assessment of blood utilisation using crossmatch-to-transfusion ratio, transfusion probability and transfusion index in elective surgery: a cross-sectional observational study.
Comparison of blood utilisation indices between elective and emergency surgical procedures: a comparative cross-sectional study.
Assessment of unnecessary crossmatching and blood reservation in elective surgical cases: a cross-sectional observational study.
Comparison of component reservation and actual transfusion among common elective surgical procedures: a comparative cross-sectional study.
Assessment of maximum surgical blood ordering schedule compliance in a tertiary care hospital: a cross-sectional observational study.
Comparison of blood utilisation before and after implementation of a maximum surgical blood ordering schedule using two defined record periods: a comparative cross-sectional study.
Assessment of emergency release blood requests and subsequent compatibility testing outcomes: a cross-sectional observational study.
Comparison of emergency and routine crossmatch turnaround times in a transfusion service: a comparative cross-sectional study.
Assessment of pre-analytical errors encountered during compatibility testing: a cross-sectional observational study.
Comparison of compatibility testing errors associated with handwritten and barcode-based sample identification systems: a comparative cross-sectional study.
Assessment of wrong-blood-in-tube and sample labeling discrepancies detected before compatibility testing: a cross-sectional observational study.
Comparison of sample rejection rates from emergency, intensive care and general ward areas for pre-transfusion testing: a comparative cross-sectional study.
Assessment of antibody screen-negative crossmatch incompatibility and its underlying causes: a cross-sectional observational study.
Comparison of immediate-spin crossmatching and computer-assisted compatibility testing in antibody screen-negative patients: a comparative cross-sectional study.
Assessment of the proportion of crossmatched red cell units actually transfused within a defined hospital population: a cross-sectional study.
Comparison of red cell reservation efficiency between high-utilisation and low-utilisation clinical departments: a comparative cross-sectional study.
Assessment of crossmatch compatibility in patients with recent transfusion history: a cross-sectional observational study.
Comparison of compatibility testing results between fresh pre-transfusion samples and samples nearing the permitted validity period: a comparative cross-sectional study.
Assessment of crossmatch incompatibility caused by cold-reactive antibodies: a cross-sectional observational study.
Comparison of prewarmed crossmatching and routine antiglobulin crossmatching in samples with cold-reactive antibodies: a comparative cross-sectional study.
Assessment of compatibility testing challenges in patients with autoimmune haemolytic anaemia: a cross-sectional observational study.
Comparison of least-incompatible unit selection and antigen-matched unit selection patterns in patients with autoantibodies: a comparative cross-sectional study.
Assessment of crossmatch difficulties in patients with multiple alloantibodies: a cross-sectional observational study.
Comparison of compatible unit availability among patients with single and multiple red cell antibodies: a comparative cross-sectional study.
Assessment of compatibility testing workload and turnaround time according to antibody screen status: a cross-sectional observational study.
Comparison of manual and automated crossmatching platforms with respect to incompatibility detection and turnaround time: a comparative cross-sectional study.

Red Cell Alloimmunisation and Autoimmunization

Prevalence of red cell alloimmunisation among multitransfused patients at a tertiary care hospital: a cross-sectional observational study.
Comparison of alloimmunisation prevalence between male and female multitransfused patients: a comparative cross-sectional study.
Assessment of red cell alloimmunisation among patients with thalassaemia major receiving regular transfusions: a cross-sectional observational study.
Comparison of alloimmunisation in thalassaemia patients receiving phenotype-matched and conventionally matched red cell transfusions: a comparative cross-sectional study.
Assessment of red cell alloimmunisation among patients with sickle cell disease: a cross-sectional observational study.
Comparison of alloantibody profiles between patients with thalassaemia and sickle cell disease: a comparative cross-sectional study.
Assessment of red cell alloimmunisation among patients with myelodysplastic syndromes receiving repeated transfusions: a cross-sectional observational study.
Comparison of alloimmunisation rates among patients with haematological and non-haematological disorders: a comparative cross-sectional study.
Assessment of alloantibody specificity among multitransfused patients with positive antibody screens: a cross-sectional observational study.
Comparison of Rh and Kell system alloantibodies among different transfusion-dependent patient groups: a comparative cross-sectional study.
Assessment of the association between number of previous transfusions and red cell alloimmunisation: a cross-sectional observational study.
Comparison of alloimmunisation prevalence among patients with lower and higher cumulative transfusion exposure: a comparative cross-sectional study.
Assessment of red cell alloimmunisation among women with previous pregnancies: a cross-sectional observational study.
Comparison of alloimmunisation prevalence between previously pregnant and never-pregnant women: a comparative cross-sectional study.
Assessment of combined effects of transfusion and pregnancy history on red cell alloimmunisation among women: a cross-sectional observational study.
Comparison of red cell alloimmunisation between RhD-negative and RhD-positive recipients: a comparative cross-sectional study.
Assessment of multiple red cell alloantibodies among chronically transfused patients: a cross-sectional observational study.
Comparison of clinical and transfusion characteristics of patients with single and multiple alloantibodies: a comparative cross-sectional study.
Assessment of red cell autoantibodies among patients undergoing pre-transfusion testing: a cross-sectional observational study.
Comparison of autoantibody prevalence among patients with autoimmune diseases and other clinical conditions: a comparative cross-sectional study.
Assessment of direct antiglobulin test positivity among hospitalised patients referred for immunohematology evaluation: a cross-sectional observational study.
Comparison of direct antiglobulin test positivity between transfused and non-transfused hospitalised patients: a comparative cross-sectional study.
Assessment of immunoglobulin G and complement patterns in direct antiglobulin test-positive patients: a cross-sectional observational study.
Comparison of monospecific direct antiglobulin test patterns among patients with autoimmune haemolytic anaemia and other conditions: a comparative cross-sectional study.
Assessment of warm autoantibodies among patients with positive direct antiglobulin tests: a cross-sectional observational study.
Comparison of serological characteristics of warm and cold autoantibodies detected in pre-transfusion samples: a comparative cross-sectional study.
Assessment of cold agglutinins among patients referred for unexplained panagglutination: a cross-sectional observational study.
Comparison of thermal amplitude and reaction strength among clinically significant and clinically insignificant cold autoantibodies: a comparative cross-sectional study.
Assessment of autoantibody-associated interference with ABO grouping and compatibility testing: a cross-sectional observational study.
Comparison of crossmatch difficulty in patients with alloantibodies alone and patients with combined alloantibodies and autoantibodies: a comparative cross-sectional study.
Assessment of alloimmunisation among patients with chronic kidney disease receiving repeated red cell transfusions: a cross-sectional observational study.
Comparison of alloimmunisation prevalence among dialysis-dependent and non-dialysis chronic kidney disease patients with transfusion exposure: a comparative cross-sectional study.
Assessment of red cell alloimmunisation among oncology patients with repeated transfusion requirements: a cross-sectional observational study.
Comparison of alloimmunisation among patients with solid malignancies and haematological malignancies: a comparative cross-sectional study.
Assessment of alloimmunisation among patients with aplastic anaemia receiving repeated red cell transfusions: a cross-sectional observational study.
Comparison of alloantibody prevalence in patients receiving leucocyte-reduced and non-leucocyte-reduced red cell components: a comparative cross-sectional study.
Assessment of the relationship between transfusion interval and alloimmunisation status among multitransfused patients at a single evaluation: a cross-sectional observational study.
Comparison of demographic and transfusion characteristics of alloimmunized and non-alloimmunized multitransfused patients: a comparative cross-sectional study.
Assessment of the frequency of evanescent or historically documented red cell antibodies among repeatedly transfused patients with available records: a cross-sectional observational study.
Comparison of current antibody screening results with documented historical alloantibody records in previously alloimmunized patients: a comparative cross-sectional study.

Advanced Immunohematology, Blood Group Phenotyping and Genotyping

Assessment of Rh C, c, E and e antigen frequencies among blood donors at a tertiary care blood centre: a cross-sectional observational study.
Comparison of Rh phenotype distribution between voluntary blood donors and multitransfused patients: a comparative cross-sectional study.
Assessment of Kell antigen frequency among blood donors in a tertiary care blood centre: a cross-sectional observational study.
Comparison of Kell phenotype distribution between blood donors and transfusion-dependent patients: a comparative cross-sectional study.
Assessment of combined Rh and Kell phenotypes among blood donors for development of an antigen-negative donor inventory: a cross-sectional observational study.
Comparison of extended red cell antigen profiles among donors from different regional or ethnic backgrounds: a comparative cross-sectional study.
Assessment of Duffy blood group antigen frequencies among blood donors: a cross-sectional observational study.
Comparison of Duffy phenotype distribution between donors and multitransfused patients: a comparative cross-sectional study.
Assessment of Kidd blood group antigen frequencies among blood donors: a cross-sectional observational study.
Comparison of Kidd phenotype distribution between healthy donors and patients with red cell alloantibodies: a comparative cross-sectional study.
Assessment of MNS blood group antigen frequencies among blood donors: a cross-sectional observational study.
Comparison of MNS phenotype frequencies among different donor age groups: a comparative cross-sectional study.
Assessment of extended red cell phenotypes among regular voluntary blood donors for identification of rare antigen-negative combinations: a cross-sectional observational study.
Comparison of antigen-negative donor availability for common clinically significant alloantibodies in routine blood bank practice: a comparative cross-sectional study.
Assessment of phenotype-matched red cell availability for thalassaemia patients with alloantibodies: a cross-sectional observational study.
Comparison of Rh and Kell antigen matching requirements among alloimmunized and non-alloimmunized thalassaemia patients: a comparative cross-sectional study.
Assessment of serological red cell phenotyping among recently transfused and non-recently transfused patients: a cross-sectional observational study.
Comparison of serological phenotyping and molecular genotyping for selected Rh antigens in multitransfused patients: a comparative cross-sectional study.
Assessment of concordance between serological phenotyping and genotyping for RhD variants: a comparative cross-sectional study.
Comparison of serological and molecular methods for identification of weak D variants: a comparative cross-sectional study.
Assessment of molecular characterization of discrepant RhD typing results among blood donors: a cross-sectional observational study.
Comparison of weak D and partial D variant distribution among donors with serologically weak RhD expression: a comparative cross-sectional study.
Assessment of red cell genotyping utility in patients with multiple alloantibodies and recent transfusion: a cross-sectional observational study.
Comparison of predicted antigen profiles by genotyping with available serological phenotypes in multitransfused patients: a comparative cross-sectional study.
Assessment of molecular blood group profiling in transfusion-dependent thalassaemia patients: a cross-sectional observational study.
Comparison of donor and recipient Rh and Kell antigen profiles in thalassaemia patients with and without alloimmunisation: a comparative cross-sectional study.
Assessment of rare blood group phenotypes among blood donors using extended serological testing: a cross-sectional observational study.
Comparison of rare antigen-negative phenotype frequency among first-time and repeat blood donors: a comparative cross-sectional study.
Assessment of Bombay and para-Bombay phenotypes among individuals with apparent group O blood type referred for discrepancy resolution: a cross-sectional observational study.
Comparison of serological characteristics of conventional group O and Bombay phenotype samples: a comparative cross-sectional study.
Assessment of secretor status among individuals with selected ABO subgroup discrepancies: a cross-sectional observational study.
Comparison of saliva inhibition testing and red cell serology for resolution of selected ABO subgroup discrepancies: a comparative cross-sectional study.
Assessment of adsorption and elution techniques in resolution of complex red cell antibody cases: a cross-sectional observational study.
Comparison of autologous and allogeneic adsorption methods for investigation of warm autoantibodies: a comparative cross-sectional study.
Assessment of eluate reactivity patterns in direct antiglobulin test-positive patients: a cross-sectional observational study.
Comparison of acid elution and heat elution techniques in selected immunohematology investigations: a comparative cross-sectional study.
Assessment of the utility of selected-cell panels in resolving complex red cell antibody mixtures: a cross-sectional observational study.
Comparison of conventional antibody identification panels and extended phenotyping-guided testing for complex alloantibody identification: a comparative cross-sectional study.
Assessment of extended antigen-matched donor availability for patients with clinically significant alloantibodies in a tertiary care blood centre: a cross-sectional observational study.
Comparison of serological phenotyping, antibody specificity and molecular genotyping in selected complex immunohematology cases: a comparative cross-sectional study.

Not the transfusion medicine subspeciality you need? Immunohematology and pretransfusion testing is one section of our full transfusion medicine collection — the hub page lists every subspeciality, each with its own free topic list. Updated September 2026.

Browse all Transfusion Medicine Thesis Topics →

📌 Updated for 2026–2027 MD Transfusion Medicine Immunohematology and Pretransfusion Testing admissions

The proposed designs were reviewed for feasibility across ABO/Rh discrepancies, antibody screening, compatibility testing, alloimmunisation, DAT interpretation, phenotyping and genotyping.

Most topics can be completed with routine tube or column agglutination, antibody screening and identification panels, DAT, crossmatching, historical records and selected extended phenotyping.
Advanced molecular genotyping, adsorption-elution work-up and rare phenotype testing are generally required only for selected complex questions or where already available.
Publication potential is strongest when the sample population, transfusion-history window, reference method, discrepancy algorithm and primary serological outcome are fixed before enrolment.

Generate a protocol from any topic above

Select Generate Protocol → beside any title in the list above and receive a submission-ready document built around that topic, containing all eighteen components:

Introduction / Synopsis
Research Question
Aim of the Study
Primary Objective
Secondary Objectives
Materials and Methods
Inclusion Criteria
Exclusion Criteria
Sample Size Calculation
Methodology
Statistical Analysis
Ethical Considerations
Review of Literature
References
Gantt Chart / Study Timeline
Patient Information Sheet
Consent Form
Data Collection Form

Already have your thesis title?

Generate the full immunohematology and pretransfusion testing protocol directly — objectives, methodology, sample size, statistics, timeline, references and annexures.

Generate your protocol

Alongside immunohematology and pretransfusion testing protocols and synopses, support is also available for departmental presentations, journal club presentations, ethics committee presentations, and posters and oral presentations for medical conferences — for postgraduate residents, board trainees and research scholars across India and the GCC. Prepared by a practising doctor with long experience in medical publishing and thesis supervision.

Enquire on WhatsApp →

Immunohematology and pretransfusion testing research outside India

The topics above work as research questions anywhere — what changes is the document the institution expects, and who approves it before data collection begins. The Gulf equivalent of an Indian synopsis is the immunohematology and pretransfusion testing research proposal submitted to an institutional review board, and it ordinarily carries three sections an Indian synopsis does not: a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.

Board and residency programmes — country by country

Saudi Arabia — SCFHS and the Saudi Board. Residency and fellowship training under the Saudi Commission for Health Specialties includes a research project with a set timeline, and the immunohematology and pretransfusion testing research proposal is the document prepared at the outset and cleared by the institutional review board before recruitment starts.

United Arab Emirates — DHA, DOH Abu Dhabi and MOHAP. Residents training in Dubai, Abu Dhabi and the northern emirates prepare an immunohematology and pretransfusion testing research protocol for their programme and submit it for institutional review board approval before any data are collected.

Qatar — DHP (formerly QCHP) and Hamad Medical Corporation. A immunohematology and pretransfusion testing IRB proposal is reviewed before recruitment, with the ethics section written to the institution's own template rather than a generic one.

Bahrain — NHRA. Trainees turning immunohematology and pretransfusion testing research topics into a project need the proposal cleared by their institutional research and ethics committee before fieldwork begins.

Oman — OMSB. Residency programmes under the Oman Medical Specialty Board include a research component, and the immunohematology and pretransfusion testing research proposal is the document assessed at the start of it.

Kuwait — KIMS. A immunohematology and pretransfusion testing study protocol goes to the institutional committee for approval before the project begins.

Arab Board programmes across the region. The Arab Board carries its own research requirement irrespective of the host country, and the immunohematology and pretransfusion testing proposal follows the same structure throughout.

Generate an immunohematology and pretransfusion testing research proposal →

Postgraduate degrees — Malaysia, the Gulf and beyond

Malaysia — MMed, the National Medical Research Register and MREC. A immunohematology and pretransfusion testing dissertation proposal for a Master of Medicine programme carried out in a Ministry of Health facility must be registered on the NMRR and approved by the Medical Research and Ethics Committee before the study begins, and the guidance asks for submission four to six months ahead of data collection. Every investigator on the study team registers on the NMRR as well, so the methodology, ethics and team sections are written in far more detail than an Indian synopsis requires.

PhD and Master's candidates elsewhere. University programmes generally require a full immunohematology and pretransfusion testing research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter.

PhD and MMed proposals are written individually by a medical doctor and revised until the supervisor accepts them. They are not produced by the automated protocol generator.

Enquire about an immunohematology and pretransfusion testing PhD or MMed proposal →

🔥 Trending research areas in Immunohematology for 2026–27

Alloimmunisation in chronically transfused patients remains important because cumulative transfusion exposure and pregnancy history can substantially alter antibody risk.
Historical antibody tracking is increasingly relevant because previously documented antibodies may become serologically undetectable but remain clinically important for future transfusion support.
Extended phenotyping and antigen-negative donor inventory studies are practical because they can improve support for patients with clinically significant alloantibodies.
Serology-genotyping concordance is an emerging area in recently transfused or complex patients where conventional phenotyping may be unreliable.

Protocol and synopsis guidance

What an immunohematology protocol must contain

An immunohematology protocol should define the exact testing domain being studied. ABO and Rh grouping, antibody screening, antibody identification, compatibility testing, DAT, alloimmunisation, autoimmunisation, phenotyping and genotyping require different workflows and reference standards.

Serological method: State whether testing uses conventional tube, column agglutination, solid phase, automation or another validated platform. The phase of testing, reagent cells, reaction grading and repeat-testing rules should be predefined.

Discrepancy resolution: ABO or Rh discrepancies should follow a structured algorithm using repeat testing, washed cells, saline replacement, subgroup studies, antiglobulin testing or other appropriate methods. Technical and clerical causes should be separated from true biological variants.

Transfusion history: Recent transfusion can produce mixed red-cell populations and invalidate serological phenotyping. The protocol should define the transfusion-history window and specify when genotyping, adsorption or selected-cell testing is required.

Immunohematology synopsis versus immunohematology protocol

The synopsis gives the academic committee the research question, rationale, objectives, design, broad laboratory methods, sample size, statistical approach and ethics in concise form. It should demonstrate that the required serological or molecular testing is routinely available.

The full protocol must specify reagents, platforms, screening and identification panels, test phases, autocontrol, DAT methods, crossmatching technique, discrepancy-resolution algorithm and handling of historical antibodies.

For method-comparison studies, the protocol should identify the reference method and define whether the objective is concordance, sensitivity, specificity or turnaround time. These outcomes should not be treated as interchangeable.

Sample size and statistical analysis

Sample size should be based on the primary objective. Prevalence studies need an expected proportion and precision; method-comparison studies need an anticipated agreement or difference; diagnostic studies require assumptions about sensitivity and specificity; and alloimmunisation studies need enough positive cases for clinically meaningful subgroup analysis.

Agreement between two serological methods may require kappa, while sensitivity and specificity require a valid reference standard. Multiple antibodies in the same patient should not be treated as independent patient observations when analysing alloimmunisation prevalence.

Multivariable models should remain realistic for the available sample and may account for age, sex, transfusion history, pregnancy history, number of prior transfusions, underlying diagnosis and test platform when these factors influence the primary outcome.

Frequently Asked Questions – Immunohematology And Pretransfusion Testing (2026–27)

1. How should I choose a feasible immunohematology thesis topic for 2026–2027 MD Transfusion Medicine admissions?

Choose a question that matches the blood centre's routine pretransfusion workload and available serological methods. Feasible projects commonly focus on ABO or Rh discrepancies, antibody screening, alloimmunisation, crossmatch incompatibility, DAT positivity, blood utilization, phenotyping or selected advanced immunohematology work-up. A strong thesis should have one clearly defined primary outcome and should use a predefined serological or molecular reference pathway.

2. Which study designs are suitable for immunohematology and pretransfusion testing research?

Cross-sectional observational and comparative studies are suitable for discrepancy patterns, antibody prevalence, compatibility problems, DAT positivity and antigen frequencies. Diagnostic or method-comparison studies can compare tube, column, solid-phase, automated or molecular methods when the reference method is defined. Retrospective record studies are practical for historical antibodies, turnaround time, blood utilization and complex compatibility work-ups.

3. What should I settle with my guide before finalising an immunohematology protocol?

Fix the exact test system, sample population, transfusion history window, antibody-screen method, identification pathway, reference standard, compatibility method and primary outcome before data collection. The protocol should also define how recently transfused patients, autoantibodies, mixed-field reactions and inconclusive antibody panels will be handled.

4. How should blood group discrepancies be studied?

Forward and reverse grouping discrepancies should be categorised separately and investigated with a predefined resolution algorithm. Repeat testing, washed cells, saline replacement, subgroup testing, antiglobulin methods, secretor studies or other advanced techniques may be used only when clinically indicated and available. The protocol should distinguish technical or clerical errors from true biological variants.

5. What is the difference between an immunohematology synopsis and protocol?

The synopsis is the concise academic submission containing the research question, rationale, objectives, design, sample size, broad laboratory methods, statistical plan and ethics. The full protocol is the operational document and should specify reagents, test phases, screening cells, identification panels, autocontrol, DAT methods, compatibility testing, transfusion-history definitions and discrepancy-resolution steps in enough detail for another laboratory to reproduce the study.

6. What ethical issues should an immunohematology thesis address?

Most studies can use anonymised blood-bank and laboratory records and may qualify for waiver of individual consent where permitted by the ethics committee. No additional donor or patient venepuncture, molecular testing or extended serology should be added solely for research unless specifically justified and approved. Identifiers should be removed from analytical datasets, and clinically significant antibodies or compatibility concerns identified prospectively should be communicated through the standard transfusion-service pathway.

7. What is the sharpest methodological problem in immunohematology research?

The sharpest problem is interpreting serological results without accounting for recent transfusion, autoantibodies or mixed red-cell populations. These can invalidate phenotyping, complicate antibody identification and create misleading crossmatch patterns. The protocol should therefore predefine transfusion-history windows, autocontrol or DAT interpretation and when genotyping or adsorption techniques are required.

8. Can an immunohematology topic be adapted for PhD, Saudi Board, Arab Board or Gulf research requirements?

Yes. An MD Transfusion Medicine synopsis usually addresses a focused serological, compatibility or blood-group question that can be completed during residency, whereas a PhD proposal generally requires a broader laboratory or population framework, deeper methodological justification and a larger programme of work. Board pathways may also require a separate research project, including SCFHS and Saudi Board requirements, the Arab Board of Health Specializations, and research components linked to DHP, DHA, DOH and MOHAP training programmes. The core immunohematology question can often be retained, but governance, validation and molecular methods should be adapted to the relevant institution or board.

9. When should I register my immunohematology thesis study?

Registration and institutional approvals should be completed before prospective sample collection or study-specific testing begins. The final protocol, test platform, reference method, transfusion-history definition, discrepancy algorithm and statistical plan should be settled first. Retrospective projects should clarify ethics approval and access to historical serology, antibody and compatibility records before extraction.

Found a topic that fits your department?

Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.

Generate your protocol